Gadolinium Hypersensitivity: Review of Four Cases

Authors

  • Margarida Gomes Serviço de Imunoalergologia, Unidade Local de Saúde Santa Maria, Portugal https://orcid.org/0000-0002-4435-4252
  • Sofia Cosme Ferreira Serviço de Imunoalergologia, Hospital Dr. Nélio Mendonça, Funchal, Portugal https://orcid.org/0000-0002-0920-1779
  • Ana Bernardino Serviço de Imunoalergologia, Hospital de Santa Maria, Unidade Local de Saúde de Santa Maria EPE, Lisboa, Portugal https://orcid.org/0000-0002-9782-0659
  • Pedro Figueiredo Serviço de Imunoalergologia, Hospital de Santa Maria, Unidade Local de Saúde de Santa Maria EPE, Lisboa, Portugal https://orcid.org/0009-0004-2143-1034
  • Maria Inês Silva Serviço de Imunoalergologia, Hospital de Santa Maria, Unidade Local de Saúde de Santa Maria EPE, Lisboa, Portugal https://orcid.org/0000-0002-8041-1306
  • Fátima Cabral Duarte Serviço de Imunoalergologia, Hospital de Santa Maria, Unidade Local de Saúde de Santa Maria EPE, Lisboa, Portugal https://orcid.org/0000-0002-0323-9936

DOI:

https://doi.org/10.25748/arp.42815

Keywords:

Gadolinium, Drug hypersensitivity, Anaphylaxis.

Abstract

Immediate hypersensitivity reactions to gadolinium-based contrast agents are uncommon but can be life-threatening. We describe four cases of immediate hypersensitivity reactions to gadobutrol, including anaphylaxis. All patients underwent allergy work-up, with positive skin prick tests to gadobutrol. Two patients also demonstrated cross-reactivity to gadoteric acid. Disodium gadoxetate was tolerated in all cases in magnetic resonance. These findings highlight the importance of individualized allergy work-up to guide safe future imaging.

Downloads

Published

2026-01-19

Issue

Section

Clinical Cases